Replies to post #69283 on Decision Diagnostics Corp (DECN)
04/09/20 3:54 PM
Once and if they pass the FDA data testing guidelines given after the PRE-EUA approval letter, they would be able to manufacture, sell and distribute immediately.
As of this writing, work has commenced on the product specification...with components such as the platinum electrodes, platinum carbon paste, industrial films (several types) to make the biosensor, and perhaps a new impedance chip for the meter. The company is operating on an 8-week development schedule and is some 10 days into this schedule. The current development cycle is considered advanced development. For FDA EUA filing and the granting of a Pre-EUA by the FDA, the company is preparing its final working concept filing, to be completed within days of this writing.
In the next 120 days the company expects to enter the Covid-19 test kit market with unique, cost effective, accurate and wholly proprietary products.
04/09/20 5:08 PM
04/09/20 5:32 PM
04/09/20 5:50 PM
04/09/20 6:27 PM
04/10/20 11:31 AM
Our plan is designed to bring at least 100,000 of our kits to market in the USA and Canada, and another 100,000 in Europe, during the month of May 2020.
…We expect the vast majority of the 420 million test kits we plan to manufacture in the first year of production will be sold to individuals for self-testing."
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |